參考文獻(xiàn)/References:
[1] 渠寧,王鈺婷,馬奔,等.2022年度甲狀腺癌研究及診療新進(jìn)展[J].中國(guó)癌癥雜志,2023,33(5): 423-430.
[2] Abutalib M A, Shams A, Tamur S, et al. Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature [J]. J Med Case Rep, 2023,17(1):521.
[3] Zhou J, Zhao B, Liu L, et al. A nomogram for individualized prediction for cervical lymph node metastasis of papillary thyroid carcinoma [J]. Gland Surg, 2024,13(11):1965-1976.
[4] Masui T, Adachi S, Uemura H, et al. Risk factors for the lateral cervical lymph node metastasis of papillary thyroid carcinoma: a clinical study[J]. Mol Clin Oncol, 2023,18(4):25.
[5] Yu Y, Shi L L, Zhang H W, et al. Performance of contrast-enhanced ultrasound for lymph node metastasis in papillary thyroid carcinoma: a meta-analysis [J]. Endocr Connect, 2023,12(2):2049-3614.
[6] García-Silva S, Peinado H. Mechanisms of lymph node metastasis: an extracellular vesicle perspective [J]. Eur J Cell Biol, 2024,103(3):151447.
[7] Kim D, Kwon H K, Shin S C, et al. Right posterior paratracheal lymph nodes metastasis is one of the predictive factors in right-sided papillary thyroid carcinoma [J]. Surgery, 2019,166(6):1154-1159.
[8] Li S, Ren C, Gong Y, et al. The role of thyroglobulin in preoperative and postoperative evaluation of patients with differentia-ted thyroid cancer[J]. Front Endocrinol(Lausanne),2022,13:872527.
[9] Kim H, Park S Y, Choe J, et al. Preoperative serum thyroglobulinand its correlation with the burden and extent of differentiatedthyroid cancer[J]. Cancers(Basel),2020,12(3):625.
[10] 李山奇,謝宛辰,殷雪東,等.血清學(xué)指標(biāo)與甲狀腺乳頭狀癌頸部淋巴結(jié)轉(zhuǎn)移的相關(guān)性研究[J].中華內(nèi)分泌外科雜志,2024,18(4):515-519.
[11] Su X, Lin L, Weng J, et al. TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer[J]. Cancer Biomark, 2019, 26(4):461-470.
[12] Russ G, Bonnema S J, Erdogan M F, et al. European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the eutirads [J]. Eur Thyroid J, 2017, 6(5): 225-237.
[13] Yu X, Song X, Sun W, et al. Independent risk factors predicting central lymph node metastasis in papillary thyroid microcarcinoma [J]. Horm Metab Res, 2017, 49(3): 201-207.
[14] Liu T, Deng L, Lin H, et al. Exploring the application of FNA-Tg for the diagnosis of cervical lymph node metastasis in PTC [J]. Eur J Surg Oncol, 2024,51(2):109489.
[15] Song Y, Xu G,Wang T, et al. Surgeon-performed fine-needle aspiration for lymph nodes behind the big cervical vessels in papillary thyroid cancer [J]. Laryngoscope Investig Otolaryngol, 2022,7(2):646-651.
[16] Luo L, Luo Q, Tang L. Diagnostic value and clinical signifi-cance of MRI and CT in detecting lymph node metastasis of early cervical cancer [J]. Oncol Lett, 2020,19(1):700-706.
[17] Giovanella L,Bongiovanni M,Trimboli P. Diagnostic value ofthyroglobulin assay in cervical lymph node fine-needle aspira-tions for metastatic differentiated thyroid cancer[J]. Curr Opin Oncol,2013,25(1):6-13.
[18] Su X, Shang L, Yue C, et al. Ultrasound-guided fine needle aspiration thyroglobulin in the diagnosis of lymph node metastasis of differentiated papillary thyroid carcinoma and its influencing factors [J]. Front Endocrinol(Lausanne),2024,15:1304832.
[19] Al-Hili Z, Strajina V, McKenzie T J, et al. Thyroglobulin measurement in fine-needle aspiration improves the diagnosis of cervical lymph node metastases in papillary thyroid carcinoma [J]. Ann Surg Oncol, 2017, 24(3): 739-744.
[20] 崔亭亭,李儼育, 王茜,等.細(xì)針穿刺洗脫液甲狀腺球蛋白診斷甲狀腺乳頭狀癌頸部淋巴結(jié)轉(zhuǎn)移的閾值及效能分析[J].中華醫(yī)學(xué)超聲雜志,2023,20(2):219-225.
[21] 楊汶士,張艷,張鳳鳳,等.細(xì)針穿刺洗脫液測(cè)定甲狀腺球蛋白和細(xì)針穿刺細(xì)胞學(xué)診斷甲狀腺乳頭狀癌頸部淋巴結(jié)轉(zhuǎn)移的Meta分析[J].腫瘤研究與臨床,2022,34(2):137-141.
[22] Zhan J, Zhang L H, Yu Q, et al. Prediction of cervical lymph nodemetastasis with contrast-enhanced ultrasound and association betweenpresence of BRAF(V600E)and extrathyroidal extension inpapiliary thyroid carcinoma[J]. Ther AdvMed Oncol,2020,12:1758835920942367.
[23] 陳啟陽(yáng),劉玉江,劉金蘋(píng),等.基于超聲造影的預(yù)測(cè)模型對(duì)甲狀腺乳頭狀癌頸中央?yún)^(qū)淋巴結(jié)轉(zhuǎn)移的診斷價(jià)值[J].中華醫(yī)學(xué)超聲雜志,2023,20(4):442-448.
[24] 徐秋棟, 李國(guó)鋒, 沈潛,等.CEUS診斷甲狀腺乳頭狀癌的影像學(xué)表現(xiàn)及對(duì)頸部淋巴結(jié)轉(zhuǎn)移的診斷效能[J].中華內(nèi)分泌外科雜志,2023,17(4):445-449.
[25] 蘇曉妮,曹軍英,蔣南,等.剪切波彈性成像定量參數(shù)預(yù)測(cè)甲狀腺乳頭狀癌頸部淋巴結(jié)轉(zhuǎn)移的價(jià)值[J].中國(guó)臨床實(shí)用醫(yī)學(xué),2022,13(3):7-10.
[26] Xing Z, Qiu Y, Yang Q, et al. Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis [J]. Eur J Radiol,2020,129:109103.
[27] 魏培英, 蔣念東, 韓志江,等.CT強(qiáng)化程度對(duì)甲狀腺乳頭狀癌頸部淋巴結(jié)轉(zhuǎn)移的診斷價(jià)值[J].中華內(nèi)分泌外科雜志,2020,14(2):144-147.
[28] 袁育韜,邢金琳,謝克飛,等.CT征象及BRAFV600E基因突變與甲狀腺乳頭狀癌中央?yún)^(qū)淋巴結(jié)轉(zhuǎn)移的相關(guān)性[J].中華普外科手術(shù)學(xué)雜志,2023,17(6):611-614.
[29] 陳雅梅, 徐杰,李騰,等.甲狀腺乳頭狀癌容積比與淋巴結(jié)轉(zhuǎn)移關(guān)系的研究[J].中華普通外科雜志,2023,38(10):744-748.
[30] 孟艷飛,飛勇,王娜,等.雙能量 CT 碘圖定量參數(shù)聯(lián)合形態(tài)學(xué)征象預(yù)測(cè)甲狀腺微小乳頭狀癌頸部中央?yún)^(qū)淋巴結(jié)轉(zhuǎn)移的價(jià)值[J].國(guó)際放射醫(yī)學(xué)核醫(yī)學(xué)雜志,2022,46(10):599-605.
[31] 王奕文,周哲,孫占國(guó),等.磁共振成像在甲狀腺結(jié)節(jié)診斷中的研究進(jìn)展[J].磁共振成像,2023,14(8):150-153.
[32] 孫漢麟, 殷珂宇,李紅強(qiáng),等.≥55歲甲狀腺乳頭狀癌患者中央?yún)^(qū)淋巴結(jié)轉(zhuǎn)移的臨床預(yù)測(cè)模型構(gòu)建與驗(yàn)證[J].中華內(nèi)分泌外科雜志,2024,18(1):45-50.
[33] 馬偉瓊,陳康胤,楊寧,等.多參數(shù)MRI影像組學(xué)對(duì)甲狀腺乳頭狀癌頸部淋巴結(jié)的術(shù)前評(píng)估價(jià)值[J].磁共振成像,2022,13(10):108-113.
[34] Lin P, Yao Z, Sun Y, et al. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples [J]. J Proteomics, 2019(204):103414.
[35] Ding X, Liu Y, Zhao J, et al. A novel wavelet-transform-based convolution classification network for cervical lymph node metastasis of papillary thyroid carcinoma in ultrasound images [J]. Comput Med Imaging Graph,2003(109):102298.